Neil Shneider

Characterization of Antigen-Specific Immune Response in ALS

National Institute of Neurological Disorders and Stroke · RF1

PI · $3.2M · Mayo Clinic Arizona

Access for All in ALS (ALL ALS) West Clinical Coordinating Center

National Institute of Neurological Disorders and Stroke · OT2

PI · $76.5M · St. Joseph's Hospital and Medical Center

Silence ALS: A Platform for the Discovery and Development of Antisense Therapeutics for Patients with Ultra-Rare Forms of ALS

National Institute of Neurological Disorders and Stroke · U01

Contact PI · $15.9M · Columbia University Health Sciences

Corticospinal Neuron Dysfunction and Degeneration in ALS: Testing the Role of Corticomotor Connectivity in Motor Neuron Disease

National Institute of Neurological Disorders and Stroke · R01

PI · $3.4M · Winifred Masterson Burke Med Res Inst

Regulatory T Cells for Amyotrophic Lateral Sclerosis

Principal investigator · Active not recruiting · Phase 1

Cellenkos, Inc.

PREVENT ALL ALS Study

Site PI · Recruiting

St. Joseph's Hospital and Medical Center, Phoenix

ASSESS ALL ALS Study

Site PI · Recruiting

St. Joseph's Hospital and Medical Center, Phoenix

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

Site PI · Recruiting

Target ALS Foundation, Inc.